Brain stimulation safely restores sense of touch for up to decade

· Medical Xpress

by University of Pittsburgh

edited by Sadie Harley, reviewed by Andrew Zinin

Sadie Harley

Scientific Editor

Meet our editorial team
Behind our editorial process

Andrew Zinin

Chief Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source


Credit: Unsplash/CC0 Public Domain

What if people who have lost the ability to feel their hands could get that sense back—not through a prosthetic glove, but through tiny pulses of electricity delivered directly to the brain?

A decade of work by scientists at the University of Pittsburgh and the University of Chicago, published in Science Translational Medicine, shows that this approach is not only possible but safe over the long term.

Across five volunteers with spinal cord injuries, the team delivered 168 million pulses of brain stimulation via implanted brain-computer interface devices over a combined 27 years of implant time without any serious adverse events—making this the first study of its kind and the longest-running study of the safety of intracortical microstimulation in humans to date.

"This research plants a flag in the ground for the safety and utility of using brain-computer interfaces to deliver sensory stimulation in clinical settings and, eventually, in people's homes," said senior author Robert Gaunt, associate professor of physical medicine and rehabilitation and a member of Pitt's Rehab Neural Engineering Labs.

"For brain-computer interfaces to have real impact on people's lives, they need to keep working safely and reliably for years. This study shows that microstimulation in the brain can do exactly that."

From lab milestone to long test

Brain-computer interfaces, or BCIs, have captured the public's imagination in recent years, fueled by companies racing to translate the technology into products that could help people move, feel or communicate again. But the fundamental question remains: Do these systems hold up over years of daily use, and are they safe?

Pitt's Rehab Neural Engineering Labs, working with colleagues at the University of Chicago, have been at the forefront of BCI science since the early 2010s.

In 2012, the Pitt investigator-led team was among the first in the world to implant electrodes in the motor cortex to let a paralyzed person control a robotic arm and later, in 2015, pioneered the approach of stimulating the sensory cortex to pair movement with a sense of touch.

The University of Chicago then implanted its first participant with electrodes in the sensory and motor cortices in 2020.

Sensations stayed where intended

The new publication, made possible by five pioneer volunteers who committed years of their lives to the research, answers the field's most pressing long-term questions. Is stimulation safe? Do stimulation-evoked sensations drift to other parts of the body or fade over time? Are there unintended side effects? The team's answer, in short: Stimulation stayed safe, stable and localized—even after 10 years in one participant.

Working with those volunteers, the team found that electrical pulses delivered to the hand region of the somatosensory cortex evoked sensations that stayed mapped to the hand and did not shift to other body parts over time.

Those sensations rarely lingered after stimulation was switched off—on average, only one such "persistent sensation" occurred in roughly 23,000 stimulation trials, and the vast majority lasted less than 10 seconds. None were painful, and none required medical intervention.

Finally, the electrodes became less sensitive over time: 64% remained functional on average, including 60% of one participant's electrodes after a full decade in the brain, though electrodes demonstrated accelerated decay later in the study.

Path toward take-home devices

"This shows that this technology doesn't just have to be a short-term solution we test in the lab; industry can start developing long-term take-home solutions for patients," said lead author Charles Greenspon, an assistant professor in the Department of Neurological Surgery at the University of Chicago.

The implications stretch beyond touch. Because the same kind of microstimulation is being tested in other brain regions that process vision or hearing, the safety data reported in this paper lays the groundwork for clinical-grade neuromodulation devices that could one day help restore lost senses more broadly.

The University of Pittsburgh and University of Chicago collaboration is ongoing. The teams continue to improve microstimulation's capabilities, including how to make sensations feel more natural, better control the device when stimulation is turned on and simplify calibration of the many parameters that control sensations.

Publication details

Long-term safety and efficacy of intracortical microstimulation in humans, Science Translational Medicine (2026). DOI: 10.1126/scitranslmed.aec3728

Journal information: Science Translational Medicine

Key medical concepts

Spinal Cord InjuriesSomatosensory Cortex

Clinical categories

NeurologyPhysiatry Provided by University of Pittsburgh Who's behind this story?

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Brain stimulation safely restores sense of touch for up to decade (2026, July 15) retrieved 16 July 2026 from https://medicalxpress.com/news/2026-07-brain-safely-decade.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.